NO985145L - Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler - Google Patents

Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler

Info

Publication number
NO985145L
NO985145L NO985145A NO985145A NO985145L NO 985145 L NO985145 L NO 985145L NO 985145 A NO985145 A NO 985145A NO 985145 A NO985145 A NO 985145A NO 985145 L NO985145 L NO 985145L
Authority
NO
Norway
Prior art keywords
active ingredients
pharmaceutical preparations
delayed release
insoluble active
insoluble
Prior art date
Application number
NO985145A
Other languages
English (en)
Other versions
NO985145D0 (no
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Fruduric Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of NO985145L publication Critical patent/NO985145L/no
Publication of NO985145D0 publication Critical patent/NO985145D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO985145A 1996-05-06 1998-11-04 Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler NO985145D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9605630A FR2748205A1 (fr) 1996-05-06 1996-05-06 Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
PCT/EP1997/002187 WO1997041836A1 (fr) 1996-05-06 1997-04-28 Compositions pharmaceutiques pour la liberation prolongee de principes actifs insolubles

Publications (2)

Publication Number Publication Date
NO985145L true NO985145L (no) 1998-11-04
NO985145D0 NO985145D0 (no) 1998-11-04

Family

ID=9491862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985145A NO985145D0 (no) 1996-05-06 1998-11-04 Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler

Country Status (9)

Country Link
US (1) US6245346B1 (no)
EP (1) EP0896527A1 (no)
JP (1) JP2000509403A (no)
AU (1) AU710539B2 (no)
CA (1) CA2253377A1 (no)
FR (1) FR2748205A1 (no)
IL (1) IL126892A (no)
NO (1) NO985145D0 (no)
WO (1) WO1997041836A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2002058671A1 (en) * 2001-01-26 2002-08-01 Debio Recherche Pharmaceutique S.A. Burst free pharmaceutical microparticules
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
GB0122113D0 (en) * 2001-09-11 2001-10-31 Astrazeneca Ab Composition
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
EP1969940A3 (en) 2004-12-17 2008-12-10 Devgen NV Nematicidal compositions
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8604101B2 (en) 2010-03-24 2013-12-10 Basf Se Process for producing aqueous dispersions of thermoplastic polyesters
CA2791220A1 (en) 2010-03-24 2011-09-29 Basf Se Process for producing aqueous dispersions of thermoplastic polyesters
WO2012014011A1 (en) * 2010-07-26 2012-02-02 Universite De Geneve Compositions comprising polymers prepared from 2-hydroxyalkyl acids
CA2849663A1 (en) 2011-09-23 2013-03-28 Basf Se Use of an aqueous dispersion of biodegradable polyesters
WO2015158823A1 (de) 2014-04-16 2015-10-22 Veyx-Pharma Gmbh Veterinärpharmazeutische zusammensetzung und deren verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
CH679207A5 (no) 1989-07-28 1992-01-15 Debiopharm Sa
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
ES2062634T3 (es) * 1990-08-30 1994-12-16 Senju Pharma Co Composicion con liberacion controlada del farmaco.
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
CA2197327A1 (en) * 1994-09-30 1996-04-11 Shigeyuki Takada Oral sustained-release preparation
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents

Also Published As

Publication number Publication date
CA2253377A1 (fr) 1997-11-13
FR2748205A1 (fr) 1997-11-07
WO1997041836A1 (fr) 1997-11-13
AU710539B2 (en) 1999-09-23
JP2000509403A (ja) 2000-07-25
US6245346B1 (en) 2001-06-12
IL126892A0 (en) 1999-09-22
NO985145D0 (no) 1998-11-04
AU2773597A (en) 1997-11-26
IL126892A (en) 2004-07-25
EP0896527A1 (fr) 1999-02-17

Similar Documents

Publication Publication Date Title
NO985145D0 (no) Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler
IL125849A (en) Substituted benzenesulfonamide derivatives, their preparation and pharmaceutical compositions comprising them
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
HUT77235A (hu) Dermálisan alkalmazható parazita elleni készítmények, és ezek előállítása
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
DK1037614T3 (da) Dobbeltkapsel til indgivelse af aktive bestanddele til mangfoldige terapier
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
DK1210348T3 (da) Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
HUP9900865A3 (en) Anti-viral benzimidazole derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
IL149209A0 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
NO20022828D0 (no) Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for fremstilling av disse, ogfarmasöytiske preparater inneholdende disse
DZ2560A1 (fr) Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.
IT8621097A0 (it) Composizioni farmaceutiche. derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative
PL345309A1 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
PT1206253E (pt) Preparacoes farmaceuticas solidas contendo nanossois de quitosano e metodo de preparacao
MXPA01011611A (es) Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application